Inactive Instrument

Avricore Health Inc Share Price Toronto S.E.

Equities

APH

CA92143R2046

Pharmaceuticals

Financials

Sales 2022 1.77M 1.29M 103M Sales 2023 3.49M 2.55M 204M Capitalization 16.94M 12.38M 990M
Net income 2022 - 0 0 Net income 2023 - 0 0 EV / Sales 2022 17.3 x
Net cash position 2022 591K 432K 34.5M Net cash position 2023 247K 180K 14.4M EV / Sales 2023 4.79 x
P/E ratio 2022
-37.7 x
P/E ratio 2023
-24.1 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 90.31%
More Fundamentals * Assessed data
Dynamic Chart
Avricore Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Avricore's HealthTab Signs Agreement for More Rexall Pharmacy Locations MT
Avricore Health Provides Update on Q3 MT
Avricore Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Avricore Health Inc. Expands Its Innovative Point-Of-Care Chronic and Infectious Disease Screening and Health- Data Management Platform, Healthtab CI
Avricore Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Avricore Health Up Nearly 14% After Reporting Reseller Pact Between HealthTab, Abbott Rapid Dx UK & Ireland MT
Avricore Health Inc. Announces its Agreement with Ascensia Diabetes Care to Integrate Their Blood Glucose Monitoring Systems, Marketed as Contour Next Gen and Four Next One CI
HealthTab to Integrate CONTOUR NEXT Family of Blood Glucose Meters For Deeper Diabetes Patient Insights MT
Avricore Health Inc Announces Agreement with Ascensia Diabetes Cares CI
Avricore Health Inc. Announces Board Changes CI
Avricore Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Avricore Health Inc. Auditor Raises 'Going Concern' Doubt CI
Avricore Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Avricore Health's HealthTab Passes 530 Locations, Adds Virus Detection MT
More news
Managers TitleAgeSince
Chief Executive Officer - 31/12/18
Director of Finance/CFO - 05/08/19
Chief Tech/Sci/R&D Officer - 07/12/20
Members of the board TitleAgeSince
Chairman 71 19/01/16
Director/Board Member 71 26/03/18
Director/Board Member - 20/06/23
More insiders
Avricore Health Inc. is a pharmacy service company that is focused on acquiring and developing early-stage technologies. The Company is engaged in the business of health data and point-of-care technologies (POCT). It provides digital solutions that support the role of pharmacists and provide infrastructure for making clinical services more accessible and more affordable in its communities. The Company's offering includes HealthTab. HealthTab is a cloud-based network technology that enables the real-time response system where consumers receive a finger-stick blood test at their local pharmacy via a Web-enabled blood chemistry analyzer. Its HealthTab platform can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. It also provides bacterial and viral testing for Strep and COVID-19. The Company's wholly owned subsidiary is HealthTab Inc.
More about the company